Stockscreener 앱 받기
19.69
3.96%
0.75
시간 외 거래:
19.70
0.010
+0.05%
전일 마감가:
$18.94
열려 있는:
$19.1
하루 거래량:
1.73M
Relative Volume:
1.96
시가총액:
$1.68B
수익:
$139.71M
순이익/손실:
$-209.36M
주가수익비율:
-7.6318
EPS:
-2.58
순현금흐름:
$-160.60M
1주 성능:
+3.20%
1개월 성능:
+4.62%
6개월 성능:
-10.70%
1년 성능:
+33.04%
1일 변동 폭
$18.75
$19.80
1주일 범위
$18.56
$19.80
52주 변동 폭
$13.14
$25.34
Syndax Pharmaceuticals Inc Stock (SNDX) Company Profile
명칭
Syndax Pharmaceuticals Inc
전화
781-419-1400
주소
35 GATEHOUSE DRIVE, WALTHAM, MA
Syndax Pharmaceuticals Inc Stock (SNDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-01-31 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Perform |
| 2023-12-22 | 개시 | Mizuho | Buy |
| 2023-10-25 | 개시 | BofA Securities | Buy |
| 2023-10-11 | 개시 | Goldman | Buy |
| 2023-07-27 | 개시 | Scotiabank | Sector Outperform |
| 2023-07-11 | 개시 | Guggenheim | Buy |
| 2023-04-17 | 재개 | BTIG Research | Buy |
| 2023-01-31 | 개시 | Stifel | Buy |
| 2023-01-03 | 개시 | JP Morgan | Overweight |
| 2022-07-28 | 재개 | B. Riley Securities | Buy |
| 2022-04-11 | 개시 | H.C. Wainwright | Buy |
| 2022-02-15 | 개시 | Goldman | Buy |
| 2021-06-04 | 재개 | Robert W. Baird | Outperform |
| 2021-05-25 | 개시 | Citigroup | Buy |
| 2021-02-18 | 개시 | B. Riley Securities | Buy |
| 2020-12-03 | 개시 | Stifel | Buy |
| 2020-05-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-05-22 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-05-18 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-05-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-04 | 개시 | Barclays | Overweight |
| 2020-01-13 | 재확인 | H.C. Wainwright | Buy |
| 2019-03-08 | 재확인 | H.C. Wainwright | Buy |
| 2019-01-04 | 개시 | Robert W. Baird | Outperform |
| 2018-01-05 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-03-16 | 개시 | FBR & Co. | Outperform |
| 2017-03-02 | 개시 | Instinet | Buy |
| 2016-10-07 | 개시 | Guggenheim | Buy |
| 2016-03-28 | 개시 | Citigroup | Buy |
| 2016-03-28 | 개시 | JMP Securities | Mkt Outperform |
| 2016-03-28 | 개시 | Morgan Stanley | Overweight |
모두보기
Syndax Pharmaceuticals Inc 주식(SNDX)의 최신 뉴스
Syndax: Q3 Earnings Snapshot - San Antonio Express-News
Syndax Reports Third Quarter 2024 Financial Results and Provides Business Update - cnhinews.com
SNDXSyndax Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan
Syndax to Host ASH Investor Event in Person and via Webcast on December 9, 2024 - StockTitan
Syndax's Niktimvo Achieves 75% Response Rate in Pivotal GVHD Trial, New Data Shows | SNDX Stock News - StockTitan
Royalty Pharma plc and Syndax Pharmaceuticals Enter into $350 Million Royalty Funding Agreement for Niktimvo - Marketscreener.com
Syndax agrees funding with Royalty Pharma for Niktimvo US sales - Pharmaceutical Technology
Syndax secures $350 million in royalty funding from Royalty Pharma By Investing.com - Investing.com Canada
Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for Niktimvo - StockTitan
Syndax Pharmaceuticals and Royalty Pharma Enter into $350 Million Royalty Funding Agreement for Niktimvo™ - StockTitan
(SNDX) Investment Analysis - Stock Traders Daily
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - StockTitan
Syndax Announces Participation in November Investor Conferences - StockTitan
Syndax Pharmaceuticals (SNDX) Set to Announce Earnings on Tuesday - MarketBeat
Syndax to Announce Third Quarter 2024 Financial Results and Host Conference Call and Webcast on November 5, 2024 - StockTitan
Assenagon Asset Management S.A. Buys 37,079 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat
Syndax Pharmaceuticals' SWOT analysis: stock poised for growth amid FDA approvals - Investing.com India
Syndax Pharmaceuticals' SWOT analysis: stock poised for growth amid FDA approvals By Investing.com - Investing.com South Africa
Syndax Pharmaceuticals (NASDAQ:SNDX) Now Covered by UBS Group - Defense World
UBS Initiates Coverage of Syndax Pharmaceuticals (SNDX) with Buy Recommendation - MSN
Syndax Pharmaceuticals' SWOT analysis: biotech stock faces pivotal moment - Investing.com India
Syndax Pharmaceuticals' SWOT analysis: biotech stock faces pivotal moment By Investing.com - Investing.com South Africa
UBS starts SMID cap biotechs with cancer, autoimmunity focus - Seeking Alpha
Syndax Pharmaceuticals (NASDAQ:SNDX) Earns Buy Rating from Analysts at UBS Group - MarketBeat
Inspire Investing LLC Has $410,000 Stock Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World
State Street Corp's Strategic Acquisition in Syndax Pharmaceuticals - GuruFocus.com
Creative Planning Has $378,000 Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World
SNDX underperforms with a -0.35 decrease in share price - US Post News
Syndax drops as FDA extends target date for leukemia drug application - MSN
Top investors say Syndax Pharmaceuticals Inc (SNDX) ticks everything they need - SETE News
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Sold by AQR Capital Management LLC - MarketBeat
Kura downgraded to hold by Stifel, prefers rival Syndax - MSN
Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target Raised to $41.00 - MarketBeat
We Think Syndax Pharmaceuticals (NASDAQ:SNDX) Needs To Drive Business Growth Carefully - Simply Wall St
Northwestern Mutual Wealth Management Co. Invests $27,000 in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Purchased by The Manufacturers Life Insurance Company - Defense World
Dimensional Fund Advisors LP Has $1.44 Million Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat
Taking a look at what insiders are doing to gauge the Syndax Pharmaceuticals Inc (SNDX)’s direction - Knox Daily
Have you been able to find a good deal on Syndax Pharmaceuticals Inc’s shares? - US Post News
Syndax Pharmaceuticals Inc (SNDX) Q2 2024 Earnings Call Highlights: Strategic Advances and ... - Yahoo Finance
Ratios Reveal: Breaking Down Syndax Pharmaceuticals Inc (SNDX)’s Financial Health - The Dwinnex
Syndax Pharmaceuticals Inc (SNDX) rating initates by Jefferies - Knox Daily
Does Syndax Pharmaceuticals Inc (SNDX) offer a good opportunity for investors? - SETE News
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Sold by Healthcare of Ontario Pension Plan Trust Fund - MarketBeat
American Century Companies Inc. Purchases Shares of 9,803 Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World
Millennium Management LLC Acquires 383,634 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat
Analyzing Ratios: Syndax Pharmaceuticals Inc (SNDX)’s Financial Story Unveiled - The Dwinnex
Syndax Pharmaceuticals Inc [SNDX] Chief Financial Officer makes an insider purchase of 1,250 shares worth 25037.0. - Knox Daily
(SNDX) Trading Report - Stock Traders Daily
What was Syndax Pharmaceuticals Inc (SNDX)’s performance in the last session? - US Post News
Syndax Pharmaceuticals Inc (SNDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.02%
0.47%
자본화:
|
볼륨(24시간):